U.S. Infectious Respiratory Disease Diagnostics Market Size & Outlook
U.S. infectious respiratory disease diagnostics market, 2018-2030 (US$M)
Related Markets
U.S. infectious respiratory disease diagnostics market highlights
- The U.S. infectious respiratory disease diagnostics market generated a revenue of USD 12,578.2 million in 2020 and is expected to reach USD 15,985.9 million by 2028.
- The U.S. market is expected to grow at a CAGR of 3% from 2021 to 2028.
- In terms of segment, consumables was the largest revenue generating product in 2020.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
Infectious respiratory disease diagnostics market data book summary
| Market revenue in 2020 | USD 12,578.2 million |
| Market revenue in 2028 | USD 15,985.9 million |
| Growth rate | 3% (CAGR from 2020 to 2028) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2016 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Consumables, Services |
| Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Koninklijke Philips NV, BD, BioMerieux SA, Bio-Rad Laboratories Inc, QuidelOrtho Corp, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV, Roche |
Other key industry trends
- In terms of revenue, U.S. accounted for 34.9% of the global infectious respiratory disease diagnostics market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In North America, U.S. infectious respiratory disease diagnostics market is projected to lead the regional market in terms of revenue in 2028.
- Canada is the fastest growing regional market in North America and is projected to reach USD 1,038.9 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Infectious Respiratory Disease Diagnostics Market Scope
Infectious Respiratory Disease Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. infectious respiratory disease diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious respiratory disease diagnostics market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 64.77% in 2024. Horizon Databook has segmented the U.S. infectious respiratory disease diagnostics market based on instruments, consumables, services covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. market leads the infectious respiratory disease diagnostics market due to local presence of leading players such as F. Hoffmann La Roche Ltd., Abbott, and Danaher. One of the reason for their continued dominance is the presence of well-established R&D infrastructure and favorable reimbursement policies.
Furthermore, according to the WHO, around 40,675,578 confirmed cases of COVID-19 and 653,099 deaths were reported from January 2020 to September 2021. Regular testing and diagnosis during the COVID-19 and influenza outbreak boost market growth.
In addition, regulatory and reimbursement landscape is continuously evolving to adapt to the fast-paced research progress in this sector. The U.S.FDA is developing new regulatory strategies such as Emergency Use Authorization, which is anticipated to address the urgent clinical demand and boost innovation in tests, while ensuring that the data produced by these tests is accurate and reliable.
Reasons to subscribe to U.S. infectious respiratory disease diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. infectious respiratory disease diagnostics market databook
-
Our clientele includes a mix of infectious respiratory disease diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. infectious respiratory disease diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into U.S. infectious respiratory disease diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. infectious respiratory disease diagnostics market
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
